Rein Therapeutics, Inc. Common Stock RNTX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$49.87M+20.7% | -$62.88M-300% | -$15.73M+42.4% | -$27.33M-4.5% | ||
| —— | —— | $119K-29.6% | $169K+39.7% | ||
| $2.22M+99.1% | $1.12M-6.1% | $1.19M-42.9% | $2.08M-7.8% | ||
| -$19.36M+13.1% | -$22.29M-12.5% | -$19.81M+20.3% | -$24.87M-4.7% | ||
| —— | $0-100% | $96K— | $0— | ||
| $9.76M-46.6% | $18.26M— | —— | —— | ||
| -$9.65M-116% | -$4.47M-134% | $13.22M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rein Therapeutics, Inc. Common Stock generate?
- Rein Therapeutics, Inc. Common Stock (RNTX) generated -$16.6M in operating cash flow over the trailing twelve months.
- Where does Rein Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Rein Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.